RN7SK pseudogene 45 (RN7SKP45)

RN7SK pseudogene 45 is classified as a **pseudogene** of the RN7SK small nuclear RNA gene family. Pseudogenes are genomic DNA sequences similar to normal genes but are typically nonfunctional; they do not encode functional products and lack biological activity themselves. There is no evidence that RN7SK pseudogene 45 has a functional role, is expressed, or has relevance as a therapeutic target, drug interaction partner, biomarker, or disease gene. The functional small nuclear RNA RN7SK acts as a regulator of RNA polymerase II elongation via the P-TEFb complex, but information and experimental findings relate only to the parent gene RN7SK, not its pseudogenes[1][2][3]. In transcriptomic datasets, RN7SK pseudogene 45 may be detected as a nonfunctional reference locus[4]. No literature reports support a biological or clinical function for this pseudogene. Key assessment: - *RN7SKP45* is not a functional target, receptor, enzyme, or gene product with any known therapeutic, biomarker, or physiological relevance (is_target: false). - The entry is most likely *incorrect as a therapeutic target* (is_incorrect: true), because pseudogenes do not encode functional molecules and do not fit standard molecular target categories. If you seek information about the functional parental gene, that would be **RN7SK** (*RNA, 7SK small nuclear*), a long noncoding RNA that regulates transcription elongation, influences macrophage polarization, and has roles in immune modulation and cellular homeostasis[1][2][3]. However, this does not apply to RN7SK pseudogene 45, which does not have any demonstrated role or target status. In summary: RN7SK pseudogene 45 is a nonfunctional genomic relic and should not be considered a valid biological or therapeutic target.

Other names

RN7SKP45RNA, 7SK small nuclear pseudogene 45